Bynfezia Pen Injection
Product Images NDC 62756-452

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Bynfezia Pen (NDC 62756-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-octreotide-carton (Spl Octreotide Carton)

This is a product label for Beloly Bynfézia Pen, with the active ingredient octreotide acetate injection at a concentration of 2,500 mcg/mL. It comes in a 2.8 mL disposable single-patient-use pre-filled pen. The dosages available are 150 mcg, 100 mcg, 150 mcg, and 200 mcg. This medication is for subcutaneous use only and intended for single-patient use. It provides storage instructions, expiration date after opening, and proper disposal guidelines. The recommended dosage is specified, and it is emphasized not to administer using a syringe. Be cautious to keep it out of reach of children.*

FDA Label Image

Spl-octreotide-figure1 (Spl Octreotide Figure1)

FDA Label Image

Spl-octreotide-figure10 (Spl Octreotide Figure10)

FDA Label Image

Spl-octreotide-figure11 (Spl Octreotide Figure11)

FDA Label Image

Spl-octreotide-figure12 (Spl Octreotide Figure12)

FDA Label Image

Spl-octreotide-figure13 (Spl Octreotide Figure13)

FDA Label Image

Spl-octreotide-figure14 (Spl Octreotide Figure14)

FDA Label Image

Spl-octreotide-figure15 (Spl Octreotide Figure15)

FDA Label Image

Spl-octreotide-figure16 (Spl Octreotide Figure16)

FDA Label Image

Spl-octreotide-figure17 (Spl Octreotide Figure17)

FDA Label Image

Spl-octreotide-figure18 (Spl Octreotide Figure18)

FDA Label Image

Spl-octreotide-figure19 (Spl Octreotide Figure19)

FDA Label Image

Spl-octreotide-figure2 (Spl Octreotide Figure2)

FDA Label Image

Spl-octreotide-figure20 (Spl Octreotide Figure20)

FDA Label Image

Spl-octreotide-figure21 (Spl Octreotide Figure21)

FDA Label Image

Spl-octreotide-figure22 (Spl Octreotide Figure22)

FDA Label Image

Spl-octreotide-figure23 (Spl Octreotide Figure23)

FDA Label Image

Spl-octreotide-figure24 (Spl Octreotide Figure24)

FDA Label Image

Spl-octreotide-figure25 (Spl Octreotide Figure25)

FDA Label Image

Spl-octreotide-figure26 (Spl Octreotide Figure26)

FDA Label Image

Spl-octreotide-figure3 (Spl Octreotide Figure3)

FDA Label Image

Spl-octreotide-figure4 (Spl Octreotide Figure4)

FDA Label Image

Spl-octreotide-figure5 (Spl Octreotide Figure5)

FDA Label Image

Spl-octreotide-figure6 (Spl Octreotide Figure6)

FDA Label Image

Spl-octreotide-figure7 (Spl Octreotide Figure7)

This text mentions alcohol, a new pen, sharps, swabs, a needle container, and a ball. It appears to be related to medical supplies or equipment. The figure "F" might be referring to an illustration or diagram associated with these items.*

FDA Label Image

Spl-octreotide-figure8 (Spl Octreotide Figure8)

FDA Label Image

Spl-octreotide-figure9 (Spl Octreotide Figure9)

FDA Label Image

Spl-octreotide-structure.jpg (Spl Octreotide Structure)

This text mentions a molecule sequence starting with H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol, with a modification that includes xCH3COCH with the range specified as x=14 to 25. This appears to be a chemical structure or formula provided for evaluation or analysis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.